IFNAR1 and melanoma: Experiments with human malignant melanoma tissues and cell lines have shown that proinflammatory cytokines, such as IL-1α/β and TNF-α, produced by melanoma cells activate p38 kinase to promote the IFN-α/β-independent pathway of IFNAR1 degradation.